A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Clinical trial NCT03420781 · TERMINATED
Trial details
- NCT number
- NCT03420781
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2020-10-30
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.